Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024060
Filing Date
2016-08-11
Accepted
2016-08-11 16:06:11
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cdtx-10q_20160630.htm 10-Q 1183690
2 EX-31.1 cdtx-ex311_7.htm EX-31.1 9356
3 EX-31.2 cdtx-ex312_6.htm EX-31.2 9578
4 EX-32.1 cdtx-ex321_9.htm EX-32.1 6427
5 EX-32.2 cdtx-ex322_8.htm EX-32.2 6269
  Complete submission text file 0001564590-16-024060.txt   3753192

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20160630.xml EX-101.INS 716728
7 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20160630.xsd EX-101.SCH 25766
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdtx-20160630_cal.xml EX-101.CAL 26573
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdtx-20160630_def.xml EX-101.DEF 91126
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20160630_lab.xml EX-101.LAB 225015
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20160630_pre.xml EX-101.PRE 167627
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 161824621
SIC: 2836 Biological Products, (No Diagnostic Substances)